Scientists have confirmed that & # 39; the world's first drugs to stop cancer resistance to treatment will be available within 10 years.
The Cancer Research Institute in Great Britain has announced an investment of £ 75 million to develop these new drugs.
Paul Warkman, the chief executive of the Cancer Research Institute, noted that cancer's ability to adapt to drugs is the biggest challenge in treatment.
Workman said the new drugs would cure cancer in the long term and make it easier to treat & # 39; would make.
Existing treatments, such as those with chemical drugs, sometimes fail because deadly cancer cells adapt to it and cause a relapse, the researchers say.
"The ability of cancer to adjust, develop and resist drugs was the cause of the large number of cancer deaths, and it was the biggest challenge to overcome this disease," Werkman said.
He said the institute has completely changed "the way we think about cancer" and focuses on predicting how cancer cells would develop to prevent drug resistance.
The Cancer Research Institute is seeking additional £ 15 million in funding for its new drug discovery center at West London headquarters in Saten, which aims to bring together around 300 researchers from different disciplines.
Scientists are looking at new approaches, including cross-synthesis of drugs and artificial intelligence, to predict and control the development of cancer cells, and to create weaknesses that can be exploited for treatment.
"Artificial intelligence and mathematical prediction methods have an enormous ability to enter the head of cancer cells, predict what is coming and how they will respond to new treatments," said Andrea Sotoriva, deputy director of the new center.
Researchers are already working on new drugs designed to stop a type of protein molecule called Apobec that is part of the immune system, which is dominated by more than half of the cancers to develop the ability to withstand therapeutic drugs.
Warkman said that laboratory tests and clinical trials of new drugs would take about 10 years before they would be available to patients.
"We are convinced that further research will find ways to tame cancer in the long term and make it more manageable so that patients can live longer and have a better quality of life." (BBC)